Clinical Trial Update: Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR [NA]

View source ↗

Summary

A clinical trial evaluating the F2 Filter and Delivery System for embolic protection during transcatheter aortic valve replacement (TAVR) is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis

Drugs mentioned

• F2 Filter and Delivery System

Snippet

Sponsor: EnCompass Technologies, Inc. | Conditions: Aortic Stenosis Treated With TAVI, Aortic Diseases | NA | Status: RECRUITING